{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:56:03Z","timestamp":1781517363510,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.jvca.2026.03.026","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:05:27Z","timestamp":1773756327000},"page":"2004-2014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation Monitoring Strategies During Cardiopulmonary Bypass in Patients With Antiphospholipid Syndrome: A Systematic Review"],"prefix":"10.1053","volume":"40","author":[{"given":"Shotaro","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0610-9774","authenticated-orcid":false,"given":"Osamu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.03.026_bib0001","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.03.026_bib0002","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2026.03.026_bib0003","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.026_bib0004","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification Criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.jvca.2026.03.026_bib0005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jth.15217","article-title":"Monitoring of anticoagulation in thrombotic antiphospholipid syndrome","volume":"19","author":"Cohen","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.026_bib0006","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fimmu.2019.00941","article-title":"Cardiac manifestations of antiphospholipid syndrome with focus on its primary form","volume":"10","author":"Kolitz","year":"2019","journal-title":"Front Immunol"},{"key":"10.1053\/j.jvca.2026.03.026_bib0007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2026.03.026_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1749-8090-5-101","article-title":"Antiphospholipid syndrome; its implication in cardiovascular diseases: a review","volume":"5","author":"Koniari","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/02184923251321066","article-title":"Surgical outcomes of cardiac surgery in patients with antiphospholipid syndrome and systemic lupus erythematosus: a systematic review","volume":"33","author":"Agarwal","year":"2025","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1053\/j.jvca.2026.03.026_bib0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","article-title":"The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and the American society of ExtraCorporeal technology: clinical practice guidelines-anticoagulation during cardiopulmonary bypass clinical practice guidelines","volume":"105","author":"Shore-Lesserson","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0011","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2026.03.026_bib0012","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1053\/j.jvca.2016.07.001","article-title":"Pro: The Hepcon HMS should be used instead of traditional activated clotting time (ACT) to dose heparin and protamine for cardiac surgery requiring cardiopulmonary bypass","volume":"30","author":"Ural","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.026_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2020.109809","article-title":"Viscoelastic haemostatic assays in the perioperative period of surgical procedures: systematic review and meta-analysis","volume":"64","author":"Santos","year":"2020","journal-title":"J Clin Anesth"},{"key":"10.1053\/j.jvca.2026.03.026_bib0014","article-title":"Comparison of blood concentration and weight-based heparin and protamine dosing strategies for cardiopulmonary bypass: a systematic review and meta-analysis","volume":"16","author":"Raner","year":"2024","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2026.03.026_bib0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejcts.2007.11.004","article-title":"The antiphospholipid syndrome and heart valve surgery","volume":"33","author":"Gorki","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0016","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejcts.2004.12.062","article-title":"Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder?","volume":"28","author":"Massoudy","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0017","first-page":"891","article-title":"Heart valve surgery in antiphospholipid syndrome patients-morbidity and mortality","volume":"13","author":"Eviatar","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1053\/j.jvca.2026.03.026_bib0018","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jtha.2024.03.027","article-title":"Dilemmas in the diagnosis and management of antiphospholipid syndrome","volume":"22","author":"Manning","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.026_bib0019","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0310057X0303100119","article-title":"Anti-factor Xa monitoring of anticoagulation during cardiopulmonary bypass in a patient with antiphospholipid syndrome","volume":"31","author":"Lennon","year":"2003","journal-title":"Anaesth Intensive Care"},{"key":"10.1053\/j.jvca.2026.03.026_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/039139880402700113","article-title":"Aortic valve replacement and perioperative management in hemodialyzed patient wth antiphospholipid syndrome","volume":"27","author":"Lango","year":"2004","journal-title":"Int J Artif Organs"},{"key":"10.1053\/j.jvca.2026.03.026_bib0021","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/0218492314568106","article-title":"Perioperative anticoagulation management in antiphospholipid syndrome","volume":"23","author":"Ishida","year":"2015","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1053\/j.jvca.2026.03.026_bib0022","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1053\/j.jvca.2014.02.006","article-title":"Difficulties with the use of thromboelastometry in a patient with antiphospholipid syndrome undergoing cardiac surgery","volume":"29","author":"Lee","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.026_bib0023","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0218492315577879","article-title":"Severe antiphospholipid syndrome and cardiac surgery: perioperative management","volume":"24","author":"Mishra","year":"2016","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1053\/j.jvca.2026.03.026_bib0024","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jocs.13216","article-title":"Perioperative anticoagulation management during aortic valve replacement complicated by antiphospholipid syndrome","volume":"32","author":"Nakajima","year":"2017","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1213\/XAA.0000000000000439","article-title":"Management of a patient with antiphospholipid syndrome undergoing aortic valve replacement using the Hepcon hemostasis management system plus and rotational thromboelastometry: a case report","volume":"8","author":"Samejima","year":"2017","journal-title":"A A Case Rep"},{"key":"10.1053\/j.jvca.2026.03.026_bib0026","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10047-018-1032-7","article-title":"Anticoagulation management during cardiopulmonary bypass in patients with antiphospholipid syndrome","volume":"21","author":"Seki","year":"2018","journal-title":"J Artif Organs"},{"key":"10.1053\/j.jvca.2026.03.026_bib0027","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/jocs.14557","article-title":"TEG improves anticoagulation management during cardiopulmonary bypass complicated by antiphospholipid syndrome","volume":"35","author":"Nakajima","year":"2020","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1051\/ject\/202153046","article-title":"Antiphospholipid syndrome and cardiac bypass: the careful balance between clotting and bleeding","volume":"53","author":"Ural","year":"2021","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2026.03.026_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40981-021-00427-x","article-title":"Correlation between activated clotting time monitoring and heparin concentration measurement in a patient with antiphospholipid syndrome during cardiac valve surgery: a case report","volume":"7","author":"Yoshinaga","year":"2021","journal-title":"JA Clin Rep"},{"key":"10.1053\/j.jvca.2026.03.026_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/aca.aca_228_20","article-title":"Management of perioperative anticoagulation in a patient with antiphospholipid antibody syndrome undergoing cardiac surgery: a case report","volume":"25","author":"Malviya","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2026.03.026_bib0031","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1053\/j.jvca.2024.07.014","article-title":"Walking the tightrope: anticoagulation management of patients with antiphospholipid syndrome and immune thrombocytopenic purpura undergoing mitral valve replacement with cardiopulmonary bypass","volume":"38","author":"Katunaric","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.026_bib0032","first-page":"173","article-title":"[Coagulation management during open heart surgery based on a heparin dose sensitivity test for antiphospholipid antibody syndrome]","volume":"77","author":"Kimishima","year":"2024","journal-title":"Kyobu Geka"},{"key":"10.1053\/j.jvca.2026.03.026_bib0033","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1177\/02676591231197990","article-title":"Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery","volume":"39","author":"Michael","year":"2024","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2026.03.026_bib0034","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/10892532241249782","article-title":"Management of anticoagulation and antifibrinolytics in catastrophic antiphospholipid syndrome","volume":"28","author":"Park","year":"2024","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.03.026_bib0035","article-title":"Management of cardiac surgery in a patient with antiphospholipid syndrome using the heparin-activated clotting time titration curve and thromboelastography: a case report","volume":"13","author":"Sasaki","year":"2025","journal-title":"Sage Open Med Case Rep"},{"key":"10.1053\/j.jvca.2026.03.026_bib0036","series-title":"Kaplan's essentials of cardiac anesthesia","first-page":"299","article-title":"Coagulation monitoring","author":"Linda Shore-Lesserson","year":"2017"},{"key":"10.1053\/j.jvca.2026.03.026_bib0037","doi-asserted-by":"crossref","first-page":"262","DOI":"10.14740\/jmc3689","article-title":"An exceedingly rare case of antithrombin III deficiency and catastrophic antiphospholipid-like disease","volume":"12","author":"Phan","year":"2021","journal-title":"J Med Cases"},{"key":"10.1053\/j.jvca.2026.03.026_bib0038","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.03.026_bib0039","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.03.026_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-5223(05)80008-X","article-title":"The impact of heparin concentration and activated clotting time monitoring on blood conservation. Aprospective, randomized evaluation in patients undergoing cardiac operation","volume":"110","author":"Despotis","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.03.026_bib0041","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4065\/75.9.971","article-title":"Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery","volume":"75","author":"Hogan","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1053\/j.jvca.2026.03.026_bib0042","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1053\/j.jvca.2019.02.042","article-title":"Heparin\/Protamine Management With the Hepcon HMS: Is There More to Consider Than Printed Values?","volume":"33","author":"Erdoes","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"10.1053\/j.jvca.2026.03.026_bib0043","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0035-1570035","article-title":"Antifactor Xa Activity for the Management of Anticoagulation during Cardiac Surgery","volume":"64","author":"Reyher","year":"2016","journal-title":"Thorac Cardiovasc Surg"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702600248X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702600248X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:51:09Z","timestamp":1781517069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307702600248X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S105307702600248X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.03.026","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation Monitoring Strategies During Cardiopulmonary Bypass in Patients With Antiphospholipid Syndrome: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}